These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 23125424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. C3 glomerulonephritis/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families.
    Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A.
    Adv Exp Med Biol; 2013; 735():189-96. PubMed ID: 23402027
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.
    Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1436-46. PubMed ID: 21566112
    [Abstract] [Full Text] [Related]

  • 7. FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.
    Garam N, Cserhalmi M, Prohászka Z, Szilágyi Á, Veszeli N, Szabó E, Uzonyi B, Iliás A, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Rysava R, Reiterova J, Saraga M, Seeman T, Zieg J, Sládková E, Stajic N, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Józsi M, Csuka D.
    Front Immunol; 2021 Jun; 12():720183. PubMed ID: 34566977
    [Abstract] [Full Text] [Related]

  • 8. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.
    Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC.
    Lancet; 2010 Sep 04; 376(9743):794-801. PubMed ID: 20800271
    [Abstract] [Full Text] [Related]

  • 9. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.
    Frangou E, Varnavidou-Nicolaidou A, Petousis P, Soloukides A, Theophanous E, Savva I, Michael N, Toumasi E, Georgiou D, Stylianou G, Mean R, Anastasiadou N, Athanasiou Y, Zavros M, Kyriacou K, Deltas C, Hadjianastassiou V.
    Nephrol Dial Transplant; 2019 Oct 01; 34(10):1780-1788. PubMed ID: 30844074
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.
    Kidney Int; 2012 Aug 01; 82(4):465-73. PubMed ID: 22673887
    [Abstract] [Full Text] [Related]

  • 14. The role of the alternative pathway of complement activation in glomerular diseases.
    Łukawska E, Polcyn-Adamczak M, Niemir ZI.
    Clin Exp Med; 2018 Aug 01; 18(3):297-318. PubMed ID: 29450785
    [Abstract] [Full Text] [Related]

  • 15. Complement and glomerular disease: new insights.
    Pickering M, Cook HT.
    Curr Opin Nephrol Hypertens; 2011 May 01; 20(3):271-7. PubMed ID: 21422921
    [Abstract] [Full Text] [Related]

  • 16. C3 glomerulopathy: what's in a name?
    D'Agati VD, Bomback AS.
    Kidney Int; 2012 Aug 01; 82(4):379-81. PubMed ID: 22846813
    [Abstract] [Full Text] [Related]

  • 17. Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report.
    Chen P, Zhu L, Yu F, Han SS, Meng SJ, Guo WY, Zhang H, Song Y.
    Medicine (Baltimore); 2017 Jun 01; 96(24):e7144. PubMed ID: 28614243
    [Abstract] [Full Text] [Related]

  • 18. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N, Malik TH, Patel MP, Toth T, Cook HT, Tomson C, Pickering MC.
    Kidney Int; 2014 Apr 01; 85(4):933-7. PubMed ID: 24067434
    [Abstract] [Full Text] [Related]

  • 19. C3, C4, factor B and HLA-DR alpha mRNA expression in renal biopsy specimens from patients with IgA nephropathy.
    Oren R, Laufer J, Goldberg I, Kopolovic J, Waldherr R, Passwell JH.
    Immunology; 1995 Dec 01; 86(4):575-83. PubMed ID: 8567024
    [Abstract] [Full Text] [Related]

  • 20. Regulating complement in the kidney: insights from CFHR5 nephropathy.
    Gale DP, Pickering MC.
    Dis Model Mech; 2011 Nov 01; 4(6):721-6. PubMed ID: 22065842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.